ENSC
ENSC clinical trials: Ensysce Biosciences, Inc.
Every trial on ClinicalTrials.gov where Ensysce Biosciences, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 9
- As lead sponsor
- 0
- As collaborator
- 1
- Primary completions as lead sponsor, next 90 days
ENSC on the catalyst calendar · ENSC registry changes
- Primary completion Dec 22, 2026Sponsor estimatePhase 1NCT06500793Single Dose Study, Pharmacokinetics of Oxycodone and PF614 Co-Administered With Nafamostat (PF614-MPAR-102)Ensysce Biosciences · PharmacokineticsRecruitingENSCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 2026Sponsor estimatePhase 3NCT06602271PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)Ensysce Biosciences · Postoperative Pain, AcuteRecruitingENSCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 14, 2023ActualPhase 2NCT06629402Assessment of PF614 Effects on Experimental Pain in the Cold Pressure Test (PF614-201)Ensysce Biosciences · Acute PainCompletedENSCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 18, 2018ActualPhase 1NCT02454712Study of PF614 Compared to OxyContin® in Healthy Volunteers (PF614-101)Ensysce Biosciences · HealthyCompletedENSCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 23, 2022ActualPhase 1NCT05571345A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)Ensysce Biosciences · Recreational Drug UseCompletedENSCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 31, 2022ActualPhase 1NCT05567354A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)Ensysce Biosciences · Recreational Drug UseCompletedENSCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 26, 2023ActualPhase 1NCT05090280Pharmacokinetics of Oxycodone and PF614 Co-Administered with Nafamostat (PF614-MPAR-101)Ensysce Biosciences · PharmacokineticsCompletedENSCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 21, 2022ActualPhase 1NCT05043766Evaluation of Oral PF614 Relative to OxyContin (PF614-102)Ensysce Biosciences · Healthy VolunteersCompletedENSCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 11, 2020ActualPhase 1NCT04406415Oral Nafamostat in Healthy Volunteers (NAF-101)Ensysce Biosciences · PharmacokineticsCompletedENSCLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner